Device / Technology News

RSS

New computer-based approach can predict adverse reactions of drugs

Side effects are a major reason that drugs are taken off the market and a major reason why patients stop taking their medications, but scientists are now reporting the development of a new way to predict those adverse reactions ahead of time.

3 Jan 2013

New analysis on global trends in medical imaging for cardiology applications

The promise of cost and clinical benefits are spurring the penetration of imaging modalities in cardiac applications. While demographics are favouring market growth, cardiac imaging device manufacturers will have to focus on innovative, patient-friendly products that promote greater safety and easier operability.

2 Jan 2013

Halt Medical receives $15M financing for commercialization of Acessa uterine fibroid treatment system

Halt Medical, Inc. announced today that it has received $15 million of financing to support commercialization of the Acessa System, a newly FDA cleared medical device to treat uterine fibroids.

2 Jan 2013

RaySearch and Siemens terminate development and licensing agreement

In May 2009 RaySearch Laboratories entered into a long-term development and licensing agreement with Siemens Healthcare. Under the agreement RaySearch provided a number of treatment planning modules for integration in Siemens' syngo Suite for Oncology, which is Siemens' integrated workflow solution for radiation therapy.

2 Jan 2013

Abnormally narrow retinal arteries linked to increased risk for glaucoma

A new study finds that certain changes in blood vessels in the eye's retina can be an early warning that a person is at increased risk for glaucoma, an eye disease that slowly robs people of their peripheral vision.

2 Jan 2013

Study highlights value of defibrillators in typical medical settings

Patients who received an implantable heart defibrillator in everyday practice had survival benefits on par with those who received the same devices in carefully controlled clinical trials, according to a new study that highlights the value of defibrillators in typical medical settings.

1 Jan 2013

FDA clears Cepheid Xpert CT/NG molecular diagnostic test

Cepheid today announced that it has received clearance from the U.S. Food & Drug Administration to market Xpert CT/NG. Running on Cepheid's GeneXpert Systems, Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae. For the first time, same-day patient consultation and treatment is possible for the two most common sexually transmitted bacterial infections in the United States.

28 Dec 2012

BGU and CCHMC receive early stage funding to develop three new pediatric medical devices

Ben-Gurion University of the Negev (BGU) and Cincinnati Children's Hospital Medical Center (CCHMC) have received early stage funding to develop three new devices that have applications for pediatric medical markets, as part of a collaboration announced this past spring.

28 Dec 2012

Model-independent way to study ion channel gating

Two studies in The Journal of General Physiology (JGP) help pave the way for a "shortcut" model-free approach to studying activation of "polymodal" ion channels-channels that open in response to multiple stimuli. Transmembrane ion channels respond to various physiological stimuli to regulate numerous cellular functions. Different classes of channels respond to different types of stimuli; some channels, for instance, respond to changes in membrane potential whereas others are activated by ligand binding.

28 Dec 2012

New cost-effective, less invasive MRI method for diagnosis of dementia

A new way to use MRI scans may help determine whether dementia is Alzheimer's disease or another type of dementia, according to new research published in the December 26, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Dec 2012

Trovagene adds Duke University Health System to worldwide licensees of NPM1 marker for AML

Trovagene, Inc., a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML).

27 Dec 2012

European healthcare IT professional services market estimated to reach $1.93 billion in 2017

The need to enhance healthcare delivery is driving the market for IT professional services in Europe. Adoption levels are, however, being hampered by budget cuts and end user reluctance to invest in such services. These trends have triggered several changes in the market, including consolidation and the adoption of inorganic growth models.

27 Dec 2012

Study reveals decline in cancer screening rates

The rate of people who seek preventive cancer screenings has fallen over the last ten years in the United States with wide variations between white-collar and blue-collar workers, according to a University of Miami Miller School of Medicine study published on December 27 in the open-access journal Frontiers in Cancer Epidemiology.

27 Dec 2012

Alzheimer's disease or FTLD can be effectively tracked using MRI

When trying to determine the root cause of a person's dementia, using an MRI can effectively and non-invasively screen patients for Alzheimer's disease or Frontotemporal Lobar Degeneration (FTLD), according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania.

27 Dec 2012

Whole Genome Mapping and NGS deliver high-quality reference genome of domestic goat

OpGen, Inc. today announced its ARGUS Whole Genome Mapping System technology was used in combination with next-generation sequencing (NGS) to produce the first, high-quality reference genome of the domestic goat.

26 Dec 2012

Use of CT scans for children suspected of having appendicitis varies among hospitals

Children suspected of having appendicitis are more likely to receive CT scans, which involve radiation, if they are evaluated at a general hospital, a new study by Washington University School of Medicine in St. Louis has shown.

25 Dec 2012

Mobile technologies helping mothers receive health information

"Twenty years ago this month, the first text message was sent through the airwaves," Sharon D'Agostino, vice president for worldwide corporate contributions and community relations at Johnson & Johnson, writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, adding, "Since then, text messages have been used to communicate all sorts of information.

21 Dec 2012

Venaxis seeks CE Mark approval for blood-based appendicitis test

Venaxis, Inc., an in vitro diagnostic company, today announced it has filed for CE Mark approval in Europe for APPY1, the Company's blood-based appendicitis test.

21 Dec 2012

Roche, PSS partner to develop fully automated emulsion PCR instrument for sequencing

Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of next-generation sequencing platforms. It is intended to support Roche's GS Junior and GS FLX+ systems as well as the sequencing platforms that Roche is currently developing.

From Roche Sequencing and Life Science 21 Dec 2012

Novel testing reaction based on magnetic resonance data

In their quest for new agents, pharmaceutical researchers test millions of substances all over the world. They like using color-forming reactions to identify new molecules. However, in intensively colored solutions or in the case of mixtures with multiple substances these tests fail.

21 Dec 2012

Device / Technology News

New computer-based approach can predict adverse reactions of drugs

New analysis on global trends in medical imaging for cardiology applications

Halt Medical receives $15M financing for commercialization of Acessa uterine fibroid treatment system

RaySearch and Siemens terminate development and licensing agreement

Abnormally narrow retinal arteries linked to increased risk for glaucoma

Study highlights value of defibrillators in typical medical settings

FDA clears Cepheid Xpert CT/NG molecular diagnostic test

BGU and CCHMC receive early stage funding to develop three new pediatric medical devices

Model-independent way to study ion channel gating

New cost-effective, less invasive MRI method for diagnosis of dementia

Trovagene adds Duke University Health System to worldwide licensees of NPM1 marker for AML

European healthcare IT professional services market estimated to reach $1.93 billion in 2017

Study reveals decline in cancer screening rates

Alzheimer's disease or FTLD can be effectively tracked using MRI

Whole Genome Mapping and NGS deliver high-quality reference genome of domestic goat

Use of CT scans for children suspected of having appendicitis varies among hospitals

Mobile technologies helping mothers receive health information

Venaxis seeks CE Mark approval for blood-based appendicitis test

Roche, PSS partner to develop fully automated emulsion PCR instrument for sequencing

Novel testing reaction based on magnetic resonance data

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News